Poster Elodie Laridan onderzoeksdag 2015
Transcription
Poster Elodie Laridan onderzoeksdag 2015
Geneeskunde Neutrophil extracellular traps: a novel target in acute ischemic stroke? Elodie Laridan Promotor: Prof. Dr. Ir. Simon De Meyer Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium INTRODUCTION WHY ARE NEUTROPHIL EXTRACELLULAR TRAPS SO IMPORTANT? Ischemic stroke is one of the major causes of death sustained disability worldwide. It results from a blood clot impairing blood flow to the brain causing irreversible tissue damage (ischemia). Unfortunately, the use of tissue plasminogen activator (t-PA) as only therapeutic has many limitations and fails to dissolve blood clots in some cases. This suggests that other unknown factors may be involved in clot stability. In addition, reperfusion of damaged brain tissue leads to additional tissue injury caused by a complex interplay of inflammation and blood clotting (thrombosis). Neutrophil extracellular traps (NETs) are a new link between thrombosis and inflammation. NETs are formed when neutrophils expulse their DNA forming a net with immunological properties. They can also promote blood clot formation by attracting platelets (see figure below) and potentially form a support for blood clot formation and stabilization. NET markers in blood have been shown to reflect disease activity in several clotting diseases, but little is known about their role in stroke. Remove blood clot Time lost = brain lost Ischemic stroke Therapy fails in some cases: WHY? Defense against bacteria NETs • Blood clot formation • Blood vessel and brain tissue damage Do NETs support blood clot formation explaining in part why therapy fails? Do NETs further contribute to stroke progression? HOW TO INVESTIGATE? NET formation in damaged (ischemic) brain area following stroke? • Mouse model of ischemia/reperfusion • Detection of NETs with antibodies DNase1 as NETs degrading enzyme: ability to help dissolve blood clots? • In vitro testing • Mouse model of cerebral blood clot formation Biomarkers for NETs in plasma from acute stroke patients? Detection of typical NETs markers NETs in human blood clots from acute stroke patients? Searching for NETs in blood clots using antibodies elodie.laridan@kuleuven-kulak.be
Similar documents
North America Clot Management Devices Market Size, Application Analysis, Regional Outlook, Competitive Strategies and Forecasts to 2020
The new report, North America Clot Management Devices Market Outlook to 2021, provides key market data on the North America Clot Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Peripheral Venous Thrombectomy Devices and Embolectomy Balloon Catheters.
More information